The Europe Cell Separation Market should witness market growth of 10.0% CAGR during the forecast period (2023-2030).
The market is anticipated to develop due to rising government support for cell-based research, a growing emphasis on customized treatment, and technical advancements. The market has experienced rapid expansion due to rising investments in cell biology research and an increase in market participants in developing nations. Adopting several cutting-edge tools & procedures is anticipated to boost market expansion due to rising R&D activity in the pharmaceutical and biotechnology sectors.
Cell separation can also determine whether chemotherapeutic treatments are necessary. In light of this, the rising cancer incidence spurs a study in this field. The development of a new generation of cell separation systems that can process single-cell suspensions at high speed is also a result of advancements in computer, optical, and laser technology. These advantages will significantly impact market growth throughout the projection period.
There is rising demand for cell separation solutions for drug discovery & development in the biotechnology and pharmaceutical sectors. Increasing incidence of cancer and other conditions requiring cell-based therapies. Technological developments that improve the precision and effectiveness of cell separation techniques. Increasing research & development expenditures for novel uses of cell separation technology.
As per the UK governments’ report named “Future of an ageing population”, by 2040, in UK, nearly one in seven people is projected to be aged over 75. By 2037, there are projected to be 1.42 million more households headed by at least one person aged 85 or over an increase of 161% over 25 years. The proportion of the working age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050, an increase of over 5.5 million people. According to report on the French ageing policy, published by UN; as in other European countries, France faces a continuous and significant increase in the number of elderly people: in 2012, there were 15 million of people aged more than 60 years old in France. This number will reach 24 million in 2060. The growing ageing population raises the risk of chronic disease prevalence to increase further rising the growth opportunities for market.
The Germany market dominated the Europe Cell Separation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,135.1 million by 2030. The UK market is exhibiting a CAGR of 9.1% during (2023-2030). Additionally, The France market would experience a CAGR of 10.8% during (2023-2030).
Based on Product Type, the market is segmented into Consumables (Reagents, Kits, Media, & Sera, Disposables, and Beads), and Instruments (Centrifuges, Flow Cytometers, Filtration Systems, and Magnetic-activated Cell Separator Systems). Based on End-Use, the market is segmented into Biotechnology & Biopharmaceutical Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Laboratories, and Cell Banks. Based on Cells Type, the market is segmented into Animal Cell, and Human Cell. Based on Technique, the market is segmented into Centrifugation, Surface Marker, and Filtration. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, and Therapeutics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Corning Incorporated, Terumo Corporation, STEMCELL Technologies, Inc. and Akadeum Life Sciences, Inc.
The market is anticipated to develop due to rising government support for cell-based research, a growing emphasis on customized treatment, and technical advancements. The market has experienced rapid expansion due to rising investments in cell biology research and an increase in market participants in developing nations. Adopting several cutting-edge tools & procedures is anticipated to boost market expansion due to rising R&D activity in the pharmaceutical and biotechnology sectors.
Cell separation can also determine whether chemotherapeutic treatments are necessary. In light of this, the rising cancer incidence spurs a study in this field. The development of a new generation of cell separation systems that can process single-cell suspensions at high speed is also a result of advancements in computer, optical, and laser technology. These advantages will significantly impact market growth throughout the projection period.
There is rising demand for cell separation solutions for drug discovery & development in the biotechnology and pharmaceutical sectors. Increasing incidence of cancer and other conditions requiring cell-based therapies. Technological developments that improve the precision and effectiveness of cell separation techniques. Increasing research & development expenditures for novel uses of cell separation technology.
As per the UK governments’ report named “Future of an ageing population”, by 2040, in UK, nearly one in seven people is projected to be aged over 75. By 2037, there are projected to be 1.42 million more households headed by at least one person aged 85 or over an increase of 161% over 25 years. The proportion of the working age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050, an increase of over 5.5 million people. According to report on the French ageing policy, published by UN; as in other European countries, France faces a continuous and significant increase in the number of elderly people: in 2012, there were 15 million of people aged more than 60 years old in France. This number will reach 24 million in 2060. The growing ageing population raises the risk of chronic disease prevalence to increase further rising the growth opportunities for market.
The Germany market dominated the Europe Cell Separation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,135.1 million by 2030. The UK market is exhibiting a CAGR of 9.1% during (2023-2030). Additionally, The France market would experience a CAGR of 10.8% during (2023-2030).
Based on Product Type, the market is segmented into Consumables (Reagents, Kits, Media, & Sera, Disposables, and Beads), and Instruments (Centrifuges, Flow Cytometers, Filtration Systems, and Magnetic-activated Cell Separator Systems). Based on End-Use, the market is segmented into Biotechnology & Biopharmaceutical Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Laboratories, and Cell Banks. Based on Cells Type, the market is segmented into Animal Cell, and Human Cell. Based on Technique, the market is segmented into Centrifugation, Surface Marker, and Filtration. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, and Therapeutics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Corning Incorporated, Terumo Corporation, STEMCELL Technologies, Inc. and Akadeum Life Sciences, Inc.
Scope of the Study
By Product Type
- Consumables
- Reagents, Kits, Media, & Sera
- Disposables
- Beads
- Instruments
- Centrifuges
- Flow Cytometers
- Filtration Systems
- Magnetic-activated Cell Separator Systems
By End-Use
- Biotechnology & Biopharmaceutical Companies
- Research Laboratories & Institutes
- Hospitals & Diagnostic Laboratories
- Cell Banks
By Cells Type
- Animal Cell
- Human Cell
By Technique
- Centrifugation
- Surface Marker
- Filtration
By Application
- Biomolecule Isolation
- Cancer Research
- Stem Cell Research
- Tissue Regeneration
- In Vitro Diagnostics
- Therapeutics
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Corning Incorporated
- Terumo Corporation
- STEMCELL Technologies, Inc.
- Akadeum Life Sciences, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Europe Cell Separation Market by Product Type
Chapter 6. Europe Cell Separation Market by End-Use
Chapter 7. Europe Cell Separation Market by Cells Type
Chapter 8. Europe Cell Separation Market by Technique
Chapter 9. Europe Cell Separation Market by Application
Chapter 10. Europe Cell Separation Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Corning Incorporated
- Terumo Corporation
- STEMCELL Technologies, Inc.
- Akadeum Life Sciences, Inc.
Methodology
LOADING...
